Pharmacological content of tablets sold as "ecstasy": results from an online testing service
about
Toxicity of amphetamines: an update3,4-methylenedioxymethamphetamine (MDMA): current perspectivesComparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell linesContent of ecstasy in the Netherlands: 1993-20085-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot StudyIllicit drug use among rave attendees in a nationally representative sample of US high school seniors.Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaquesResidual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.Influences of activity wheel access on the body temperature response to MDMA and methamphetamine.Methylone and monoamine transporters: correlation with toxicityN-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques.Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteersDetection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMANeuroimaging in human MDMA (Ecstasy) users.Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.Adulterants in illicit drugs: a review of empirical evidence.Social, policy, and public health perspectives on new psychoactive substances.The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison.Association of study characteristics with estimates of effect size in studies of ecstasy use.Underreporting of ecstasy use among high school seniors in the US.The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.Multiple MDMA (Ecstasy) overdoses at a rave event: a case series.Combination effects of amphetamines under hyperthermia - the role played by oxidative stress.Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.There's something about Molly: The underresearched yet popular powder form of ecstasy in the United States.Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.Chronic administration of amphetamines disturbs development of neural progenitor cells in young adult nonhuman primates.Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.Acute MDMA and Nicotine Co-administration: Behavioral Effects and Oxidative Stress Processes in Mice
P2860
Q22252794-8A8F4119-8940-4D22-9AEA-85FA04A0D1BEQ24602762-86263DA8-7F5B-4393-BC53-1AC5E260B0A1Q24670108-100CA161-33D0-4054-96F1-D4C3755AB5C2Q28260437-4EFE349A-881A-4381-AD69-BDEEEF0D57A1Q28546929-D69BCF92-1CA0-4B2C-BE3C-960BD749C782Q30374944-B40610F5-A54F-4DCB-A956-DA8A8F790D4EQ30389467-AECA67C7-4EBC-4E32-818A-6697C5FE2DF5Q30393293-5D567A93-61AD-4F77-B9FF-3485CBF807C5Q34552306-788E3D64-D56D-4275-8051-9EA8A60A05D9Q34645841-A0BF2208-ED1B-4213-80E2-78CE284B0F92Q35085894-756F8DF5-C1C0-4846-8E58-2ADC8A18A477Q35107886-1803ECC7-D4C4-4CAE-85A4-BFAF82D2B8CBQ35671537-9F13EE4D-2A9A-4BE8-B942-7F3CBE431B6DQ35851128-CF394346-D434-4CA0-BC0A-A98562A55970Q35989723-9DFC5525-1FC4-48A1-876F-616EBB739BC1Q36502642-A4329FF1-1B2E-4EBA-A171-7F4A16AD1E1BQ36689382-4C73ECF6-7627-485E-9966-5E46C59F8603Q36703786-9DD23FC1-8369-4F3F-A839-C4A659CF5BEBQ37181415-49C82664-152C-4AE7-9AB1-A0CD11901E9BQ37381303-E2C8F882-3F27-4DB1-A782-A0821C0041B5Q37842265-F9410CFF-6C0B-497D-8728-11B48662D1F0Q37899850-CB22A713-3DDC-43AE-86B3-4F2D06E29CA3Q37928627-C0C257F0-401E-4DCF-A52D-26597C3AA8FDQ37936690-F6E2BA9D-5124-49CE-81B6-125E4351DCAFQ38853734-8FC935C6-A655-419E-9DBB-978B8808F31BQ39273495-9F906632-73F7-4452-9E61-E7CA0B9B232FQ39989208-72DD1CC6-9EE6-4406-8471-0F8268175CBFQ44321580-4FAD5840-6D11-4D06-86B2-D7F4EFDC782BQ46026105-F80B1C4F-FB68-491F-A9AA-ED9CAC32464BQ46150848-836A5240-5B66-44A3-B956-5B7A9DFFAE48Q47147672-ECFD5436-A51A-4452-8A45-FF01D30B441EQ50064387-1FB9F3BF-1097-4E36-81D3-67D0F3376AB6Q51017359-ADC0A25B-CC37-4EB5-B8C9-E794BBC9EBAFQ51732157-E0372A21-AF65-4B13-A676-CDD6AC5475D9Q52298136-9D719FF3-A763-4659-B44A-2D13E47D25F9Q58803432-7C8613F4-4E63-4B5C-81D2-75E92DA5E4A4
P2860
Pharmacological content of tablets sold as "ecstasy": results from an online testing service
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacological content of tab ...... from an online testing service
@ast
Pharmacological content of tab ...... from an online testing service
@en
Pharmacological content of tab ...... from an online testing service
@nl
type
label
Pharmacological content of tab ...... from an online testing service
@ast
Pharmacological content of tab ...... from an online testing service
@en
Pharmacological content of tab ...... from an online testing service
@nl
prefLabel
Pharmacological content of tab ...... from an online testing service
@ast
Pharmacological content of tab ...... from an online testing service
@en
Pharmacological content of tab ...... from an online testing service
@nl
P1476
Pharmacological content of tab ...... from an online testing service
@en
P304
P356
10.1016/J.DRUGALCDEP.2005.11.016
P407
P577
2006-07-27T00:00:00Z